• +44 1158 88 137
  • info@surrogacybypons.com
  • Mon-Fri: 08:00AM - 07:00PM | Sat: 8:00AM - 5:00PM
  • PONS

Our Surrogacy and Reproductive Technologies

Our Technology

Technological advances are an important part of today’s world. Many procedures and achievements that were unthinkable only 10-20 years ago are now a reality and we can just imagine what will be in the future. Surrogacy and Reproductive Technologies are here to stay and develop further. Infertility problems are unfortunately an increasingly serious issue, especially in Western Countries. Environmental factors, quality of life, stress, there are uncountable reasons behind this trend, with sperm quality parameters pluming to half of the levels they were 20 years ago. With these objectives conditions present it is logical to understand why fertility clinics and specially surrogacy have experimented a sharp increase during the last years. A broken society now faces the choice to become stint or somehow solve the fertility problems that it has created. Many couples have decided not to give up and they constitute the customers of our Surrogacy Programs.

Fertility and other issues affecting pregnancy are solved nowadays using In Vitro Fertilization techniques and similar procedures. These techniques are not something really new but they have become more and more popular to the extent that fertility problems worsen. We can find today advanced fertility clinics in almost every medium-size city of high income and middle income countries. The problem becomes even worse when IVF procedures are not enough and the couple needs to resort to Surrogacy as a last chance to fulfill their dream to complete their families. Surrogacy is forbidden in most of countries and face opposition from radical religious and feminist groups. In this sense only a few countries, mainly ex-Soviet states have promulgated favorable laws for Surrogacy.

Pons Medical Research was born with the aim of providing genetic and reproductive medical services to couples with serious infertility and medical problems. We have currently staff and offices in Georgia and Ukraine where we work with long established and reliable medical partners. While do we have a clinical staff group that control the Surrogacy Process at every stage we mostly pursuit a business model in which we outsource the IVF services to local partners while concentrating our capacities in medical research, genetic testing and VIP customer assistance.


Pons Medical Research works actively in the field of Human Genetics, thanks to which we are able to genetically diagnose embryos before we proceed to transfer them into the woman’s uterus.

Preimplantation Genetic Diagnosis (PGD) is a method allowing the elimination of the risk of passing on genetic disorders from the genetic parents to a child before the mother or the surrogate mother gets pregnant. By examining the embryo cells, we are able to determine whether its DNA contains any defects. For some couples it is the only way to have healthy child. In the course of the IVF procedure, embryos are tested for genetic disorders and only those that are totally free from genetic disarrays are transferred into the uterus.

We need to point out that a Surrogacy Program may fail due to abnormal implantation of the embryo in the uterus. The reason for this may be the occurrence of chromosomal aneuploidy (smaller or larger amount of chromosomes than the exact number of them in the cell). The implantation of aneuploid embryos may lead to the birth of a sick child e.g. with Klinefelter, Down, Patau, Edwards or Turner syndrome. Nevertheless, most of pregnancies in such cases end in miscarriage.

PGS-NGS 360°™ Preimplantation Genetic Screening will have the following impact in your Surrogacy Program:

  • A higher rate of embryo implantation
  • Lower risk of miscarriage
  • Low risk of birth abnormalities
  • Shorter surrogacy process
  • Lower overall cost

Through the PGD-NGS diagnostics, all chromosomes are screened and tested. Among others, we can detect the following disorders:

  • 45, X – Turner Syndrome
  • 47, XXY – Klinefelter Syndrome
  • 47, XX,+21; 47, XY,+21 – Down Syndrome
  • 47, XX, +18; 47, XY, +18 – Edwards Syndrome
  • 47, XX, +13; 47, XY, +13 – Patau Syndrome
  • Risk of miscarriages (trisomies of chromosomes 2, 7, 15, 16, 17, 22)
  • Monosomies (a chromosome missing from the pair) – may contribute to embryo implantation failure
Surrogacy and Reproductive Technologies

NGS platform Ion Torrent Thermo Fisher

Ion chips